The Technology

DehydraTECH™'s patented technology improves the way active
ingredients enter the bloodstream.

This technology aids in delivering a host of competitive advantages, providing better, more predictable cannabis experiences for consumers. Findings from extensive scientific studies include:


Reduces time of onset In studies, delivery into the bloodstream, has been measured in as little as 2 minutes. Effects of different API’s are commonly felt within minutes compared to conventional oral dosage forms which may require up to 60-120 minutes for onset to begin.


Increases Bioabsorption By 5x Bioabsorption into the blood circulation increases up to 500%. Bioabsorption into brain tissue, in repeated studies, increases by 200% to 1,900%, opening possibilities for improved drug delivery for central nervous system disorders such as Alzheimer’s and Parkinson’s.


Masks Taste & Odor Eliminates the strong tastes/odors of many bitter lipophilic compounds, without the need for unwanted sugar or sweeteners.


Avoids First-Pass Liver Metabolism By achieving higher levels of bioavailability, the APIs enter the bloodstream faster and cleaner than today’s standard emulsified products.

DehydraTECH is one of the world’s newest technologies specifically designed to improve the efficacy of orally administered bioactive molecules, including antiviral drugs, nicotine, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), and other molecules.

Learn More